Fig. 1
From: miR-486-5p predicted adverse outcomes of SCAP and regulated K. pneumonia infection via FOXO1
a-c. Increasing serum miR-486-5p was observed in patients with SCAP (a), which discriminate SCAP relative to healthy individuals (b) and patients with MCAP (c). d-f. miR-486-5p was positively correlated with LAC (r = 0.682, d), PCT (r = 0.769, e), and PSI (r = 0.741, f). *P < 0.05, ***P < 0.001, ****P < 0.0001